Agenda

C5’s Pharma and Biotech Patent Litigation conference is the largest annual gathering of leading in-house IP counsel, patent prosecutors and litigators, judges, and IP policy experts from around the globe.

Attend this event and come away with the knowledge and skills you need to address post-filing patent litigation challenges, and optimise your patent litigation strategy to continously deliver efficient patent protection in a competitive marketplace.

REQUEST BROCHURE
09:00 – 12:30

Trade Secret Working Group: Developing A Robust Trade Secret Framework Within Your Organisation
14:00 – 17:30

The U.S. Hatch-Waxman Act and Paragraph IV Litigation: Introduction to ANDA Litigation and Its Related Regulatory Schematic
8:00

Registration & Networking Refreshments
9:00

Co-Chairs’ Opening Remarks
9:10

The Status of the Unified Patent Court in this Era of Political Uncertainty
9:45

The Changing Rules of Procedure at the European Patent Office – Boards of Appeal
10:30

Networking Break
11:00

Developing Practical Strategies for Optimizing Patent Success In Europe – U.S – Brazil
12:30

Networking Luncheon
1:30

Biologics and Biosimilar Litigation: Enhance Success in Europe – U.S. – Brazil
3:00

Networking Break
3:30

Part One – Examining Available Relief for Patent Infringement In Europe
4:30

Refreshment Break
4:45

Part Two – Patent Relief Think Tank Continued
5:45

Conclusion of Day One
9:00

Co-Chairs’ Opening Remarks
9:10

Preliminary injunctions and Compulsory Licences: Causes and Justifications

10:10

Secondary Medical Use: Understanding the Latest Judicial Decisions and Trends from German and French Courts
11:10

Networking Break
11:30

Finding Safe Harbours Around the World: Comparing and Contrasting the Research Exemptions Available in Europe and U.S.
1:00

Networking Luncheon
2:00

Doctrine of Equivalence: Adapting Your Claims To Ensure Litigation Success in Europe and The U.S.
3:00

Networking Break
3:30

Supplementary Protection Certificates: Examining Technical Intricacies in Article 3(a) and 3(d) to Enhance Patent Protection Strategies
4:30

Conference Concludes